| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $21.2M | -0.5% |
| SG&A Expense | $13.2M | +22.2% |
| Pre-tax Income | -$28.5M | -7.4% |
| Income Tax | $2K | +0.0% |
| Net Income | -$28.5M | -7.4% |
| EPS (Basic) | -$0.64 | -6.7% |
| EPS (Diluted) | -$0.64 | -6.7% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $103.7M | +207.7% |
| Short-term Investments | $23.1M | -79.8% |
| Accounts Receivable | $163K | +20.7% |
| Current Assets | $127.6M | -14.3% |
| Total Assets | $128.1M | -14.1% |
| Current Liabilities | $3.3M | -5.6% |
| Total Liabilities | $3.5M | +0.3% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.7M | -14.8% |
| Investing Cash Flow | $91.8M | +2702.4% |
| Financing Cash Flow | $926K | +1457.9% |
| Stockholders' Equity |
| $124.6M |
| -14.4% |